Ling-Ying Wu, MD
Ling-Ying Wu, MD
Chief
Cancer Hospital, Chinese Academy of Medical Sciences,
Panjianyuan nanli 17#, Chaoyang District
Beijing
China
100021
Papers:
435
Recurrent ovarian cancer patients with 3-6 month treatment-free interval or 1-2 prior chemotherapy regimens might get benefit from tumor chemosensitivity assay directed chemotherapy